ConductScience.org, home

Paper40355804

Upregulation of YY1/EZH2 and MLH1 as Therapeutic Targets for Adult T-Cell Leukemia/Lymphoma.

Shimizu T and 5 others. Cancer Sci, 2025. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. Upregulation of YY1/EZH2 and MLH1 as Therapeutic Targets for Adult T-Cell Leukemia/Lymphoma. Papers, record 40355804. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40355804

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Upregulation of YY1/EZH2 and MLH1 as Therapeutic Targets for Adult T-Cell Leukemia/Lymphoma.
PubMed
Journal
Cancer Sci
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
3
iCite
Revised in PubMed
2025-08-05
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Shimizu TTakuya
2Shindo TTakerohttps://orcid.org/0000-0002-2085-6151
3Ogawa HHanako
4Teranaka KKaori
5Watanabe AAkira
6Takaori-Kondo AAkifumi

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
YY1 Transcription FactorMajor topic
Leukemia-Lymphoma, Adult T-CellMajor topic
Enhancer of Zeste Homolog 2 ProteinMajor topic
MutL Protein Homolog 1Major topic
Humans
Up-Regulation
Gene Expression Regulation, Neoplastic
Cell Line, Tumor
Epigenesis, Genetic
Cell Proliferation

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
JP19K08812Japan Society for the Promotion of SciencePubMed
JP23K07811Japan Society for the Promotion of SciencePubMed
Grant-in-aidUehara Memorial FoundationPubMed
JP21ek0510035h0001-0003Japan Agency for Medical Research and DevelopmentPubMed

Source PubMed

Download CSV of grants

References50

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11751370Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87).Br J Haematol1991https://conductscience.org/library/papers/1751370PubMed
233075812How I treat adult T-cell leukemia/lymphoma.Blood2021https://conductscience.org/library/papers/33075812PubMed
325847015T memory stem cells are the hierarchical apex of adult T-cell leukemia.Blood2015https://conductscience.org/library/papers/25847015PubMed
428515095Prognostic index for chronic- and smoldering-type adult T-cell leukemia-lymphoma.Blood2017https://conductscience.org/library/papers/28515095PubMed
530428369YY1 Upregulates Checkpoint Receptors and Downregulates Type I Cytokines in Exhausted, Chronically Stimulated Human T Cells.iScience2018https://conductscience.org/library/papers/30428369PubMed
638383791Mechanisms of action and resistance in histone methylation-targeted therapy.Nature2024https://conductscience.org/library/papers/38383791PubMed
726361794Treatment and survival among 1594 patients with ATL.Blood2015https://conductscience.org/library/papers/26361794PubMed
840355804Upregulation of YY1/EZH2 and MLH1 as Therapeutic Targets for Adult T-Cell Leukemia/Lymphoma.Cancer Sci2025https://conductscience.org/library/papers/40355804PubMed
934433624KIR3DL1 Allotype-Dependent Modulation of NK Cell Immunity against Chronic Myeloid Leukemia.Immunohorizons2021https://conductscience.org/library/papers/34433624PubMed
1028596308Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade.Science2017https://conductscience.org/library/papers/28596308PubMed
1135030628Triple combination of BET plus PI3K and NF-κB inhibitors exhibit synergistic activity in adult T-cell leukemia/lymphoma.Blood Adv2022https://conductscience.org/library/papers/35030628PubMed
1230057145Targeting the HTLV-I-Regulated BATF3/IRF4 Transcriptional Network in Adult T Cell Leukemia/Lymphoma.Cancer Cell2018https://conductscience.org/library/papers/30057145PubMed
1328522752Mismatch Repair Proteins Initiate Epigenetic Alterations during Inflammation-Driven Tumorigenesis.Cancer Res2017https://conductscience.org/library/papers/28522752PubMed
1421228036Overexpression of Enhancer of zeste homolog 2 with trimethylation of lysine 27 on histone H3 in adult T-cell leukemia/lymphoma as a target for epigenetic therapy.Haematologica2011https://conductscience.org/library/papers/21228036PubMed
1526601161Abacavir, an anti-HIV-1 drug, targets TDP1-deficient adult T cell leukemia.Sci Adv2015https://conductscience.org/library/papers/26601161PubMed
1626028255PD-1 Blockade in Tumors with Mismatch-Repair Deficiency.N Engl J Med2015https://conductscience.org/library/papers/26028255PubMed
1715944788Methylation of the MLH1 gene in hematological malignancies.Oncol Rep2005https://conductscience.org/library/papers/15944788PubMed
1829186113Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth.Nature2017https://conductscience.org/library/papers/29186113PubMed
1924727323CADM1 expression and stepwise downregulation of CD7 are closely associated with clonal expansion of HTLV-I-infected cells in adult T-cell leukemia/lymphoma.Clin Cancer Res2014https://conductscience.org/library/papers/24727323PubMed
208437212Proliferative response of Tax1-transduced primary human T cells to anti-CD3 antibody stimulation by an interleukin-2-independent pathway.J Virol1993https://conductscience.org/library/papers/8437212PubMed

See all 50 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
42095244SWI/SNF alterations define a subgroup with poorer outcome among patients with aggressive forms of adult T-cell leukemia/lymphoma.Haematologica2026https://conductscience.org/library/papers/42095244PubMed
40867514Yin Yang 1 (YY1) as a Central Node in Drug Resistance Pathways: Potential for Combination Strategies in Cancer Therapy.Biomolecules2025https://conductscience.org/library/papers/40867514PubMed
40355804Upregulation of YY1/EZH2 and MLH1 as Therapeutic Targets for Adult T-Cell Leukemia/Lymphoma.Cancer Sci2025https://conductscience.org/library/papers/40355804PubMed

Download CSV of cited by

Genes6

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CADM123705PubTator's text mininghttps://conductscience.org/library/genes/23705NCBI Gene
CCR41233PubTator's text mininghttps://conductscience.org/library/genes/1233NCBI Gene
CD48962PubTator's text mininghttps://conductscience.org/library/genes/962NCBI Gene
EZH22146PubTator's text mininghttps://conductscience.org/library/genes/2146NCBI Gene
MSH24436PubTator's text mininghttps://conductscience.org/library/genes/4436NCBI Gene
YY17528PubTator's text mininghttps://conductscience.org/library/genes/7528NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40355804

GET https://conductscience.org/api/papers/v1/40355804/references?page=2